Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Alexander H R VareyIsabel LiMary-Ann El SharouniJulie SimonAikaterini DedeiliaSydney Ch'ngRobyn P M SawAndrew J SpillaneKerwin F ShannonThomas E PenningtonMichael RtshiladzeJonathan R StretchOmgo E NiewegAlexander C J van AkkooiRyan J SullivanGenevieve Marie BolandJeffrey E GershenwaldPaul J van DiestRichard A ScolyerGeorgina V LongJohn F ThompsonSerigne N LôPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
The MIA models offer accurate and personalized estimates of both RFS and OS in patients with stage II melanoma even in the absence of pathological staging with SN biopsy. These models were robust on external validations and may be used in everyday practice both with (ideally) and without performing SN biopsy to identify high-risk patients for further management strategies. An online tool will be available at the MIA website (Risk Prediction Tools).